MariMed Inc. (OTC:MRMD – Free Report) – Investment analysts at Ventum Cap Mkts issued their FY2026 earnings per share (EPS) estimates for MariMed in a report released on Thursday, November 7th. Ventum Cap Mkts analyst A. Semple anticipates that the company will post earnings per share of $0.00 for the year. Ventum Cap Mkts currently has a “Strong-Buy” rating on the stock. The consensus estimate for MariMed’s current full-year earnings is ($0.01) per share.
MariMed Price Performance
Shares of MRMD opened at $0.17 on Monday. MariMed has a 52-week low of $0.14 and a 52-week high of $0.39. The business’s 50-day moving average is $0.16. The company has a debt-to-equity ratio of 1.08, a quick ratio of 0.49 and a current ratio of 1.27.
MariMed Company Profile
MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.
See Also
- Five stocks we like better than MariMed
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Dividend Capture Strategy: What You Need to Know
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- How to Use the MarketBeat Excel Dividend Calculator
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
